Sunshine Lake Pharma Co., Ltd. (HKG:6887)
42.36
-0.30 (-0.70%)
At close: May 8, 2026
Sunshine Lake Pharma Market Cap
Sunshine Lake Pharma has a market cap or net worth of 24.4 billion as of May 8, 2026. Its market cap has increased by 177.82% in one year.
Market Cap
24.40B
Enterprise Value
27.93B
Revenue
5.36B
Ranking
n/a
PE Ratio
69.21
Stock Price
42.36
Market Cap Chart
Since December 29, 2015, Sunshine Lake Pharma's market cap has increased from 6.55B to 24.40B, an increase of 272.35%. That is a compound annual growth rate of 13.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 24.40B | -7.14% |
| Dec 31, 2025 | 26.27B | 212.32% |
| Dec 31, 2024 | 8.41B | 0.74% |
| Dec 29, 2023 | 8.35B | 46.00% |
| Dec 30, 2022 | 5.72B | 6.56% |
| Dec 31, 2021 | 5.37B | -30.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| China Resources Pharmaceutical Group | 32.35B |
| Simcere Pharmaceutical Group | 30.86B |
| China Medical System Holdings | 29.80B |
| Grand Pharmaceutical Group | 21.40B |
| The United Laboratories International Holdings | 19.43B |
| Fujian Haixi Pharmaceuticals | 18.57B |
| Consun Pharmaceutical Group | 12.87B |
| CanSino Biologics | 12.34B |